Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC)-Reference-Cited by-同舟云学术

Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC)

Published:2016-05-20 Issue:5 Volume:118 Page:677-680
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Bokhorst Leonard P.¹,Zappa Marco²,Carlsson Sigrid V.³⁴,Kwiatkowski Maciej⁵,Denis Louis⁶,Paez Alvaro⁷,Hugosson Jonas⁸,Moss Sue⁹,Auvinen Anssi¹⁰,Roobol Monique J.¹

Affiliation:

1. Department of Urology; Erasmus University Medical Center; Rotterdam The Netherlands

2. Unit of Clinical and Descriptive Epidemiology; ISPO; Florence Italy

3. Department of Surgery (Urology Service); Memorial Sloan Kettering Cancer Center; New York USA

4. Institute of Clinical Sciences; Sahlgrenska Academy at Gothenburg University; Gothenburg Sweden

5. Department of Urology; Kantonsspital Aarau; Aarau Switzerland

6. Oncology Centre Antwerp; Antwerp Belgium

7. Department of Urology; Hospital Universitario de Fuenlabrada; Madrid Spain

8. Department of Urology; Sahlgrenska Academy at Gothenburg University; Gothenburg Sweden

9. Centre for Cancer Prevention; Queen Mary University of London; London UK

10. School of Health Sciences; University of Tampere; Tampere Finland

Funder

national cancer research funding agencies

European funding in the form of Framework programmes

some private sponsors

unconditional grant of the former Beckman/Hybritech company

Prostate Cancer Research Foundation Rotterdam (SWOP)

Cancer Center Support Grant

National Cancer Institute

Memorial Sloan Kettering Cancer Center

AFA Insurance

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13505/fullpdf

Reference10 articles.

1. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

2. Screening for prostate cancer - the controversy that refuses to die;Barry;N Engl J Med,2009

3. The effect of study arm on prostate cancer treatment in the large screening trial ERSPC;Wolters;Int J Cancer,2010

4. Differences in treatment and outcome after treatment with curative intent in the screening and control arms of the ERSPC Rotterdam;Bokhorst;Eur Urol,2015

5. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening;Autier;J Clin Oncol,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Cancer Screening;Hematology/Oncology Clinics of North America;2024-08

2. Impact of cancer screening on metastasis: A prostate cancer case study;Journal of Medical Screening;2021-02-09

3. Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer;Journal of Contemporary Brachytherapy;2019

4. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts;Cancer;2018-05-03

5. Prostate cancer screening: And the pendulum swings;Cancer;2018-05-03